93 related articles for article (PubMed ID: 2349203)
21. Aspirin for prevention of myocardial infarction.
Mirvis DM
J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
[No Abstract] [Full Text] [Related]
22. Family history, cigarette smoking and other risk factors in patients with myocardial infarction.
Woodhouse SP; Restieaux NJ; Ablett MB; Amarasingham R; Smith BR
N Z Med J; 1981 Dec; 94(698):443-7. PubMed ID: 6950289
[TBL] [Abstract][Full Text] [Related]
23. Aspirin for prevention of myocardial infarction. A double-edged sword.
Bar-Dayan Y; Levy Y; Amital H; Shoenfeld Y
Ann Med Interne (Paris); 1997; 148(6):430-3. PubMed ID: 9538376
[TBL] [Abstract][Full Text] [Related]
24. [Acetylsalicylic acid in primary prevention of cardiovascular events; literature study].
Bredie SJ; Wollersheim HC; Verheugt FW; Thien T
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):68-72. PubMed ID: 11820060
[TBL] [Abstract][Full Text] [Related]
25. The primary prevention of myocardial infarction.
Manson JE; Tosteson H; Ridker PM; Satterfield S; Hebert P; O'Connor GT; Buring JE; Hennekens CH
N Engl J Med; 1992 May; 326(21):1406-16. PubMed ID: 1533273
[No Abstract] [Full Text] [Related]
26. [Primary prevention of cardiovascular disease].
Gohlke H
Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
[No Abstract] [Full Text] [Related]
27. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
[TBL] [Abstract][Full Text] [Related]
28. [Intervention in risk factors and protection of target organs].
Gascón Ramón G; Bertomeu i Blanch F; Baño Aracil M; Madrigal JA
An Med Interna; 1997 Sep; 14(9):478-84. PubMed ID: 9453760
[TBL] [Abstract][Full Text] [Related]
29. [Prevention of myocardial infarction: priorities, principles, realities].
Kalinina AM; Chazova LV; Pavlova LI
Klin Med (Mosk); 1996; 74(5):20-3. PubMed ID: 8999175
[No Abstract] [Full Text] [Related]
30. Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
Prescrire Int; 2000 Jun; 9(47):89-90. PubMed ID: 11010752
[TBL] [Abstract][Full Text] [Related]
31. [A longitudinal study of secondary prevention of heart infarct].
Ambrosch P; Neuberger M
Offentl Gesundheitswes; 1983 Apr; 45(4):175-9. PubMed ID: 6306530
[No Abstract] [Full Text] [Related]
32. Aspirin to prevent heart attack and stroke: what's the right dose?
Dalen JE
Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
[TBL] [Abstract][Full Text] [Related]
33. The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
Gorlin R; Fuster V
Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929
[No Abstract] [Full Text] [Related]
34. [Primary prevention of coronary thrombosis by antithrombotic agents].
Milon H; Lantelme P; Khettab F; Mestre-Fernandes C; Lasserre-Remy S
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1243-50. PubMed ID: 11794965
[TBL] [Abstract][Full Text] [Related]
35. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
[TBL] [Abstract][Full Text] [Related]
36. Premature myocardial infarction in Singapore--risk factor analysis and clinical features.
Tambyah PA; Lim YT; Choo MH
Singapore Med J; 1996 Feb; 37(1):31-3. PubMed ID: 8783909
[TBL] [Abstract][Full Text] [Related]
37. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
Bots ML; Grobbee DE
J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
[TBL] [Abstract][Full Text] [Related]
38. Management of postmyocardial infarction in the elderly patient.
Forman R; Aronow WS
Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
[TBL] [Abstract][Full Text] [Related]
39. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
Alkhenizan A
BMJ; 2000 Dec; 321(7274):1472-3. PubMed ID: 11187951
[No Abstract] [Full Text] [Related]
40. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
